142 related articles for article (PubMed ID: 19016331)
21. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans.
Roy SD; Manoukian E
J Pharm Sci; 1995 Oct; 84(10):1190-6. PubMed ID: 8801333
[TBL] [Abstract][Full Text] [Related]
22. Impact of ester promoieties on transdermal delivery of ketorolac.
Liu KS; Hsieh PW; Aljuffali IA; Lin YK; Chang SH; Wang JJ; Fang JY
J Pharm Sci; 2014 Mar; 103(3):974-86. PubMed ID: 24481782
[TBL] [Abstract][Full Text] [Related]
23. Potential Use of Cyclodextrin Complexes for Enhanced Stability, Anti-inflammatory Efficacy, and Ocular Bioavailability of Loteprednol Etabonate.
Soliman OAE; Mohamed EAM; El-Dahan MS; Khatera NAA
AAPS PharmSciTech; 2017 May; 18(4):1228-1241. PubMed ID: 27469220
[TBL] [Abstract][Full Text] [Related]
24. Rapid pain relief using transdermal film forming polymeric solution of ketorolac.
Ammar HO; Ghorab M; Mahmoud AA; Makram TS; Ghoneim AM
Pharm Dev Technol; 2013; 18(5):1005-16. PubMed ID: 22191998
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, physicochemical properties and in vitro permeation studies of new ketorolac ester derivatives.
Puglia C; Filosa R; Peduto A; de Caprariis P; Boatto G; Nieddu M; Santagati NA; Bonina F
Curr Drug Deliv; 2007 Jul; 4(3):205-10. PubMed ID: 17627494
[TBL] [Abstract][Full Text] [Related]
26. Influence of cyclodextrin complexation on the in vitro permeation and skin metabolism of dexamethasone.
Lopez RF; Collett JH; Bentley MV
Int J Pharm; 2000 Apr; 200(1):127-32. PubMed ID: 10845694
[TBL] [Abstract][Full Text] [Related]
27. Drug-in-cyclodextrin-in-liposomes: A novel drug delivery system for flurbiprofen.
Zhang L; Zhang Q; Wang X; Zhang W; Lin C; Chen F; Yang X; Pan W
Int J Pharm; 2015 Aug; 492(1-2):40-5. PubMed ID: 26162980
[TBL] [Abstract][Full Text] [Related]
28. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
[TBL] [Abstract][Full Text] [Related]
29. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
[TBL] [Abstract][Full Text] [Related]
30. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
Doliwa A; Santoyo S; Ygartua P
Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
[TBL] [Abstract][Full Text] [Related]
31. Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat.
Tricarico D; Maqoud F; Curci A; Camerino G; Zizzo N; Denora N; Cutrignelli A; Laquintana V; Lopalco A; la Forgia F; Fontana S; Franco M; Lopedota A
Eur J Pharm Biopharm; 2018 Jan; 122():146-157. PubMed ID: 29079420
[TBL] [Abstract][Full Text] [Related]
32. Influence of cyclodextrin complexation with NSAIDs on NSAID/cold stress-induced gastric ulceration in rats.
Alsarra IA; Ahmed MO; Alanazi FK; Eltahir KE; Alsheikh AM; Neau SH
Int J Med Sci; 2010 Jul; 7(4):232-9. PubMed ID: 20617127
[TBL] [Abstract][Full Text] [Related]
33. Fast dissolving cyclodextrin complex of piroxicam in solid dispersion part I: influence of β-CD and HPβ-CD on the dissolution rate of piroxicam.
Bouchal F; Skiba M; Chaffai N; Hallouard F; Fatmi S; Lahiani-Skiba M
Int J Pharm; 2015 Jan; 478(2):625-32. PubMed ID: 25522828
[TBL] [Abstract][Full Text] [Related]
34. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery.
McCormack B; Gregoriadis G
Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638
[TBL] [Abstract][Full Text] [Related]
35. Ketorolac tromethamine transdermal gel: development, in vitro and in vivo evaluation.
Dubey R; Bommagani M; Venkateswarlu V; Mullangi R; Karnati HR; Thammera RK; Menon VC
J Pain Palliat Care Pharmacother; 2009; 23(1):26-34. PubMed ID: 19296352
[TBL] [Abstract][Full Text] [Related]
36. Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin.
Babu RJ; Pandit JK
Int J Pharm; 2004 Mar; 271(1-2):155-65. PubMed ID: 15129982
[TBL] [Abstract][Full Text] [Related]
37. Influence of hydroxypropyl-beta-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone.
Felton LA; Wiley CJ; Godwin DA
Drug Dev Ind Pharm; 2002 Oct; 28(9):1117-24. PubMed ID: 12455470
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of skin permeation and accumulation profiles of ketorolac fatty esters.
Bhandari KH; Newa M; Yoon SI; Kim JS; Kim DD; Kim JA; Yoo BK; Woo JS; Lyoo WS; Choi JY; Lim HT; Lee JH; Choi HG; Yong CS
J Pharm Pharm Sci; 2007; 10(3):278-87. PubMed ID: 17727791
[TBL] [Abstract][Full Text] [Related]
39. Formulation and evaluation of ketorolac transdermal systems.
Choi JS; Cho YA; Chun IK; Jung SY; Gwak HS
Drug Deliv; 2007 Feb; 14(2):69-74. PubMed ID: 17364870
[TBL] [Abstract][Full Text] [Related]
40. Nasal delivery of analgesic ketorolac tromethamine thermo- and ion-sensitive in situ hydrogels.
Li X; Du L; Chen X; Ge P; Wang Y; Fu Y; Sun H; Jiang Q; Jin Y
Int J Pharm; 2015 Jul; 489(1-2):252-60. PubMed ID: 25957699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
